RecruitingNCT06567795

PRimary IndividualiZed Evaluation of Cardiovascular Events in Patients With Diabetes Mellitus Using hemoTAG

Prospective, Multi-center, Longitudinal, Study for PRimary IndividualiZed Evaluation of Cardiovascular Events in Patients With Diabetes Mellitus Using hemoTAG


Sponsor

Aventusoft, LLC.

Enrollment

189 participants

Start Date

Mar 14, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

To evaluate the proportion of diabetic mellitus patients with CV events as measured by HEMOTAG.


Eligibility

Min Age: 40 Years

Plain Language Summary

Simplified for easier understanding

This study evaluates a blood test called HEMOTAG for predicting heart attack and stroke risk in people with type 2 diabetes. Researchers want to see if this test can better identify which diabetic patients are most at risk for serious cardiovascular events compared to standard tests. **You may be eligible if:** - You are over 40 years old - You have had type 2 diabetes (insulin-dependent or not) for at least 5 years - You have cardiovascular disease (heart disease, stroke, or circulation problems in the legs) OR have at least one diabetes complication (eye, kidney, or nerve damage, or high inflammation) plus two or more risk factors (high blood pressure, high cholesterol, obesity, or smoking history) - You are willing to undergo the HEMOTAG test and standard follow-up **You may NOT be eligible if:** - You are under 40 years old - You have had type 2 diabetes for less than 5 years - You do not meet the cardiovascular disease or complication criteria above Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEHemotag

Hemotag non-invasive medical device is used to see cardiac function for DM2 patients at-home for 30 days


Locations(1)

Metabolic Research Institute, Inc

West Palm Beach, Florida, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06567795


Related Trials